GBLX S&P BIOTECH ETF UNITS (CURE) Short Interest

GBLX S&P BIOTECH ETF UNITS (ASX:CURE) had 0.21% of shares reported as short positions as of 5 July 2026, representing 1,377 shares. Source: ASIC short position report (T+4 delay).

Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.